背景:慢性呼吸系统疾病(CRDs)可能会导致器官和身体组织的氧气利用率降低,导致缺血性损伤的风险增加,会导致脑组织损伤.这种损害会导致无数的神经症状,导致认知能力下降。认知干预可能会减轻CRD患者的认知缺陷;然而,这些影响尚未在文献中得到系统的总结。
目的:本系统综述的目的是评估认知干预(包括认知行为疗法和经颅脑刺激)对认知功能(主要结果)的影响,HRQL,自我管理,症状,身体活动,物理功能,完成日常生活活动的能力(ADL),入院,功能能力,功能性能,心理和社会结果,恶化,医疗保健利用,以及患有CRD的个体的生存。
方法:本综述将根据Cochrane干预措施系统评价手册进行,并按照PRISMA(系统评价和荟萃分析的首选报告项目)指南进行报告。搜索将在MEDLINE中执行,Embase,Emcare,PsycINFO,Scopus,和CINAHL。如果文章侧重于认知干预对患有CRD的成年人的影响,发表在同行评审的期刊上,用英语写的,法语,或者葡萄牙语。偏倚的风险将评估与Cochrane风险的偏见2工具的随机对照试验,以及非随机干预研究工具中的偏倚风险。如果至少有2项研究为特定结果提供了足够的数据,则将进行荟萃分析。TheGrade(GradingofRecommendations,评估,发展,和评估)评估将用于评估证据的整体质量。
结果:这项系统审查于2022年11月启动,并于2023年2月在PROSPERO注册,然后进行标题和摘要筛选。文章的全文筛选将于2023年6月完成。手稿的数据提取和起草将于2023年7月至2023年8月进行,预计将于2024年2月出版。
结论:本系统综述将总结认知干预对CRD患者认知功能的影响。它将指导医疗保健专业人员选择基于证据的策略,以增强具有CRD的个人的认知福祉和整体健康结果。此外,它将确定研究差距并突出未来探索的领域,支持研究人员推进这一领域的知识。
背景:PROSPEROCRD42023396234;https://tinyurl.com/mwjrfbxv。
■PRR1-10.2196/48235。
BACKGROUND: Chronic respiratory diseases (CRDs) may cause reduced oxygen availability to organs and body tissues, leading to an increased risk for ischemic damage, which can result in brain tissue injury. This damage can lead to a myriad of neurological symptoms contributing to cognitive decline. Cognitive interventions may attenuate cognitive deficits in people with CRDs; however, the effects have not yet been systematically summarized in the literature.
OBJECTIVE: The purpose of this systematic review is to assess the effects of cognitive interventions (including cognitive behavioral therapy and transcranial brain stimulation) on cognitive function (primary outcome), HRQL, self-management, symptoms, physical activity, physical function, ability to complete activities of daily living (ADLs), hospital admissions, functional capacity, functional performance, psychological and social outcomes, exacerbations, healthcare utilization, and survival in individuals with CRDs.
METHODS: This review will be conducted in accordance with the Cochrane handbook for systematic reviews of interventions and reported following the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) guidelines. Searches will be performed in MEDLINE, Embase, Emcare, PsycINFO, Scopus, and CINAHL. Articles will be included if they focus on the effects of cognitive interventions on adults with CRDs, are published in peer-reviewed journals, and are written in English, French, or Portuguese. Risk of bias will be evaluated with the Cochrane Risk of Bias 2 tool for randomized controlled trials, and the Risk of Bias in Non-randomized Studies of Interventions tool for nonrandomized studies. Meta-analyses will be performed if at least 2 studies provided sufficient data for a specific outcome. The GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) assessment will be used to evaluate the overall quality of the evidence.
RESULTS: This systematic review was initiated in November 2022 and registered with PROSPERO in February 2023, prior to title and abstract screening. Full-text screening of articles will be completed in June 2023. Data extraction and drafting of the manuscript will occur from July 2023 to August 2023, with expected publication in February 2024.
CONCLUSIONS: This systematic review will summarize the effects of cognitive interventions on cognitive function in people with CRDs. It will guide health care professionals in selecting evidence-based strategies to enhance cognitive well-being and overall health outcomes for individuals with CRDs. Additionally, it will identify research gaps and highlight areas for future exploration, supporting researchers in advancing knowledge in this field.
BACKGROUND: PROSPERO CRD42023396234; https://tinyurl.com/mwjrfbxv.
UNASSIGNED: PRR1-10.2196/48235.